The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models
Abstract
The striatum is a major forebrain nucleus that integrates cortical and thalamic afferents and forms the input nucleus of the basal ganglia. Striatal projection neurons target the substantia nigra pars reticulata (direct pathway) or the lateral globus pallidus (indirect pathway). Imbalances between neural activity in these two pathways have been proposed to underlie the profound motor deficits observed in Parkinson's disease and Huntington's disease. However, little is known about differences in cellular and synaptic properties in these circuits. Indeed, current hypotheses suggest that these cells express similar forms of synaptic plasticity. Here we show that excitatory synapses onto indirect-pathway medium spiny neurons (MSNs) exhibit higher release probability and larger N-methyl-d-aspartate receptor currents than direct-pathway synapses. Moreover, indirect-pathway MSNs selectively express endocannabinoid-mediated long-term depression (eCB-LTD), which requires dopamine D2 receptor activation. In models of Parkinson's disease, indirect-pathway eCB-LTD is absent but is rescued by a D2 receptor agonist or inhibitors of endocannabinoid degradation. Administration of these drugs together in vivo reduces parkinsonian motor deficits, suggesting that endocannabinoid-mediated depression of indirect-pathway synapses has a critical role in the control of movement. These findings have implications for understanding the normal functions of the basal ganglia, and also suggest approaches for the development of therapeutic drugs for the treatment of striatal-based brain disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“which may give rise to an aberrant learning that further impairs automatic motor behavior 45, 46.”
From Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease (2013) · cites this paper as [46]
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Short-Term Synaptic Plasticity
Zucker, R. S., & Regehr, W. G. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.092501.114547 · Cited by 5,068
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,655
The Synaptic Organization of the Brain
(2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195159561.001.1 · Cited by 3,574
The Glutamate Receptor Ion Channels
Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01394-2 · Cited by 3,554
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes
Gong, S., Zheng, C., Doughty, M. L., Losos, K., Didkovsky, N., Schambra, U. B., Nowak, N. J., Joyner, A., Leblanc, G., Hatten, M. E., et al. (2003) · Nature · doi:10.1038/nature02033 · Cited by 2,108
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,078
Graybiel, A. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00593-5 · Cited by 1,051
Cited by
Sorted by citations
Items 601–700 of 732
Optical Approaches to Studying the Basal Ganglia
Plotkin, J. L., Guzmán, J. N., Schwarz, N., Kress, G. J., Wokosin, D. L., & Surmeier, D. J. (2011) · Neuromethods · doi:10.1007/978-1-61779-298-4_10 · Cited by 2
Tripp, A. C., Kota, R. S., Lewis, D. A., & Sibille, E. L. (2010) · Cited by 2
Endocannabinoid Signaling in the Striatum
Lovinger, D. M., & Mathur, B. N. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00010-6 · Cited by 5
Postsynaptic synucleins mediate vesicular exocytosis of endocannabinoidsPreprint
Albarran, E., Sun, Y., Liu, Y., Raju, K., Dong, A., Li, Y., Wang, S., Südhof, T. C., & Ding, J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.04.462870 · Cited by 2
Sparse innervation and local heterogeneity in the vibrissal corticostriatal projectionPreprint
Amroune, K., Fontolan, L., Baude, A., Robbe, D., & Bureau, I. (2025) · eLife · doi:10.7554/elife.106621 · Cited by 2
Functional Aspects of the Basal Ganglia
Wichmann, T. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780199609536.003.0004 · Cited by 1
Murer, M. G., & Moratalla, R. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-21992-4.00019-1 · Cited by 1
Alhosaini, K. A., Alanazi, M. M., Alsulaihim, I. N., Alonazi, A. S., Alasmari, F. F., & Khan, M. R. (2026) · Drug Development Research · doi:10.1002/ddr.70273 · Cited by 1
VTA GABAergic Plasticity: An Inhibitory Synaptic Model of Drug Addiction
Nugent, F. S. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6978-1_5 · Cited by 1
Gene Functional Studies Using Bacterial Artificial Chromosome (BACs)
Liu, M., Guo, S., Battle, M., & Jonathan, K. (2011) · InTech eBooks · doi:10.5772/32167 · Cited by 1
Gaonkar, K. S., Gulati, G., Balu, K., & Purohit, R. (2012) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2012.10.007 · Cited by 1
Generation of BAC Transgenic Mice for Functional Analysis of Neural Circuits
Ting, J. T., & Feng, G. (2014) · Neuromethods · doi:10.1007/978-1-4939-1963-5_9 · Cited by 1
Emerging Role of Astrocytes in Striatal Synaptic Plasticity
Zhai, S. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2481-20.2020 · Cited by 1
Marshall, J. J., Xu, J., Yeh, N.-H., Yun, S., Nomura, T., Armstrong, J. N., Parker, J. G., & Contractor, A. (2026) · eLife · doi:10.7554/elife.98122.3 · Cited by 1
Characterizing the dynamic learning process: Implications of a quantitative analysis
Wu, M., Liu, F., Wang, H., Li, Y., Wei, C., Zheng, Q., Han, J., Liu, Z., Liu, Y., Duan, H., et al. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.114915 · Cited by 1
Advice to People with Parkinson’s in My Clinic: Cannabis
Freitas, M. E., & Fox, S. H. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230358 · Cited by 1
Pathological Synaptic Plasticity in Neurological Disorders
Jin, C., & Karlstedt, K. (2025) · Synaptic Plasticity - Neurobiology, Neuroanatomy, and Clinical Neuroscience · doi:10.5772/intechopen.1007753 · Cited by 1
Cannabinoids and Levodopa-Induced Dyskinesia
Giuffrida, A., & Martinez, A. A. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6503-3_14 · Cited by 1
Non-human Primate Models of Parkinson's Disease and Experimental Therapeutics
Petzinger, G. M., Togasaki, D. M., Akopian, G. K., Walsh, J. P., & Jakowec, M. W. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00009-9 · Cited by 1
Kuepper, R., Morrison, P. D., van Os, J., Murray, R. M., Kenis, G., & Henquet, C. (2012) · Psiquiatría Biológica · doi:10.1016/j.psiq.2012.09.005 · Cited by 1
Cannabinoid Modulation of Dopaminergic Circuits in Neurodegenerative and Neuropsychiatric Disorders
Matricon, J., & Giuffrida, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6_5 · Cited by 1
Elevated striatal dopamine and efference copy failure in schizophrenia
Vukadinovic, Z. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.040 · Cited by 1
The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases
Coccurello, R., & Bisogno, T. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2016.1209111 · Cited by 1
Optogenetic Dissection of the Striatal Microcircuitry
Silberberg, G., & Planert, H. (2016) · Neuromethods · doi:10.1007/978-1-4939-3411-9_8 · Cited by 1
Rationale for Surgical Interventions in Movement Disorders
Wichmann, T., & DeLong, M. R. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00075-7 · Cited by 1
7.3 Dopaminergic Modulation of Striatal Glutamatergic Signaling in Health and Parkinson’s Disease
Surmeier, D. J., Day, M., Gertler, T. S., Chan, C. S., & Shen, W. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0025 · Cited by 1
Regulation of Corticostriatal Synaptic Plasticity in Physiological and Pathological Conditions
Filippo, M. D., & Calabresi, P. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00023-4 · Cited by 2
Fox, S. H., & Faust‐Socher, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.00510-1 · Cited by 1
Snider, N. T. (2009) · Deep Blue (University of Michigan) · Cited by 1
Lipid Metabolism in Neurodegenerative Diseases
Lim, L., Shui, G., & Wenk, M. R. (2012) · Wiley eBooks · doi:10.1002/9783527655946.ch14 · Cited by 2
Functional Anatomy of the Motor and Non‐Motor Circuitry of the Basal Ganglia
Smith, Y. (2011) · Parkinson s Disease · doi:10.1002/9781444397970.ch4 · Cited by 1
Threlfell, S., & West, A. R. (2014) · Wiley eBooks · doi:10.1002/9781118836507.ch11 · Cited by 1
Non‐Dopaminergic Approaches to the Treatment of Parkinson's Disease
Fox, S. H., & Brotchie, J. M. (2011) · Parkinson s Disease · doi:10.1002/9781444397970.ch38 · Cited by 1
Fox, S. H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374105-9.00444-5 · Cited by 1
Marshall, J. J., Xu, J., Yeh, N.-H., Yun, S., Nomura, T., Armstrong, J. N., Parker, J. G., & Contractor, A. (2024) · eLife · doi:10.7554/elife.98122 · Cited by 1
Marshall, J. J., Xu, J., Yeh, N.-H., Yun, S., Nomura, T., Armstrong, J. N., Parker, J. G., & Contractor, A. (2024) · eLife · doi:10.7554/elife.98122.1 · Cited by 1
Striatal Nitric Oxide–cGMP Signaling in an Animal Model of Parkinson’s Disease
West, A. R., Sammut, S., & Ariano, M. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-252-0_11 · Cited by 1
Effects of cannabidiol and cannabis extracts in models of convulsion and excitotoxicity
Utan, A. (2008) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/824
Cannabinoid-Dopamine Interactions: Modulation of Midbrain DA Neurons by Endocannabinoids
Georges, F. E., & Melis, M. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_17
Kannabisaren terapiarako erabilera mugimenduaren asalduretan
Morera‐Herreras, T., Miguélez, C., Aristieta, A., Ruíz-Ortega, J. Á., & Torrecilla, M. (2013) · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria · doi:10.1387/ekaia.11048
Epidemiological and biological mechanisms of cannabis as cause of psychosis
Kuepper, R. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120504rk
The Corticostriatal Transmission in Parkinsonian Animals: In Vivo Studies
Ballion, B., Mallet, N. P., Moine, C. L., Murer, M. G., & Gonon, F. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-252-0_10
Gleeson, P., Steuber, V., & Silver, R. A. (2008) · Elsevier eBooks · doi:10.1016/b978-012373649-9.50008-9
Functional Selectivity at the Dopamine D2 Receptor
Peterson, S. M. (2015)
Endocannabinoid Mediated Long-Term Depression at Inhibitory Synapses
Chiu, C. Q., & Castillo, P. E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6978-1_11
Mesocorticolimbic adaptations in synaptic plasticity underlie the development of alcohol dependence
Jeanes, Z. M. (2012) · Texas ScholarWorks (Texas Digital Library)
O’Connell, N. (2008) · Nurse Prescribing · doi:10.12968/npre.2008.6.6.29607
Toward a Model of Retrograde Regulation of Striatal Synaptic Depression: Figure 1.
Bertran‐Gonzalez, J., & Napier, I. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1133-11.2011
Molecular basis of L-DOPA-induced dyskinesia : Studies on striatal signaling
Santini, E. (2009) · Figshare
Evans, R. C., Blackwell, K. T., Damodaran, S., Cressman, J. R., & Jȩdrzejewski-Szmek, Z. (2015)
Computational Modeling of the Basal Ganglia : Functional Pathways and Reinforcement Learning
Berthet, P. (2015) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Pre-synaptic cholinergic and cannabinergic signaling in the expression of organophosphate toxicity
Baireddy, P. (2009) · SHAREOK (University of Oklahoma; Oklahoma State University; Central Oklahoma University)
Corticostriatal plasticity modulation: New roads for therapeutic targets
Pelosi, A. (2016) · Movement Disorders · doi:10.1002/mds.26559
10.5937/mckg48-5899 = Functional and anatomical aspects of the habenular complex of epithalamus
Marković, N., & Ognjanović, N. (2014) · Medicinski casopis · doi:10.5937/mckg48-5899
Ruggiero, R. N., Bueno-Júnior, L. S., Ross, J. B. D., Fachim, H., Padovan‐Neto, F. E., Merlo, S., Rohner, C. J. S., Ikeda, E. T., Brusco, J., & Moreira, J. E. (2011)
Anatomy and Synaptic Connectivity of the Basal Ganglia
Smith, Y. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00074-5
Dopaminergic Modulation of Glutamatergic Synaptic Plasticity in Striatal Circuits
Surmeier, D. J., Shen, W., Gertler, T. S., & Chan, C. S. (2011) · Frontiers in neuroscience · doi:10.1201/b11284-6
Impaired Dopamine–Glutamate Receptor Interactions in Some Neurological Disorders
Hickey, M. A., & Cepeda, C. (2011) · Frontiers in neuroscience · doi:10.1201/b11284-11
Measurement of Spine Density in Mouse Models of Hypodopaminergia
Bermejo, M. K. (2013) · TSpace (University of Toronto)
The role of basal ganglia circuitry in motivation
Poyraz, F. C. (2016) · doi:10.7916/d89z94qz
Cannabinoide in der Behandlung der Parkinson-Erkrankung
Gandor, F., & Ebersbach, G. (2017) · Aktuelle Neurologie · doi:10.1055/s-0043-115380
Regulation of Corticostriatal Synaptic Plasticity in Physiological and Pathological Conditions
Filippo, M. D., & Calabresi, P. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00012-3
Whalley, K. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2107x
A Role for CaMKII and ERK1/2 Pathways in Alcohol Self-Administration and Relapse-like Behavior
Salling, M. C. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/febm-qn63
Nicotine in Aberrant Learning and Corticostriatal Plasticity
Koranda, J. L., & Beeler, J. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813035-3.00023-x
Aberrant chloride homeostasis and inhibitory synaptic transmission in Huntington's disease
Dargaei, Z. (2018) · TSpace (University of Toronto)
Inflammation and accumulating risk for developing psychiatric disorders
Money, K. M. (2016)
Current state of knowledge on the use of medical marijuana in some neurological diseases
Ziętal, K., Joniec‐Maciejak, I., & Mirowska-Guzel, D. M. (2020) · Pharmacotherapy in Psychiatry and Neurology · doi:10.33450/fpn.2020.08.003
Todorov, G. I., Mayilvahanan, K., Ashurov, D., & Cunha, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-84474-5
RetractedCunha, C., Todorov, G. I., Ashurov, D., & Cunha, C. (2021) · Neurology and Neurobiology · doi:10.31487/j.nnb.2021.01.02
Pannexin-1-Dependent Long-Term Depression at the CA3-CA1 Synapse
Werner, A. C. (2021) · doi:10.11575/prism/38720
Ersättningsmodeller för ballasttransporter
Grönlund, Ö. (2012)
Pandolfo, M. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.4651956.4532054
Geschwind, D. H. (2007) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1090653.545891
Abburi, C., Thome, J., Rodriguez, B., Zhuang, X., & McGehee, D. S. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3956658
Tobin, A. J. (2007) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1092756.547674
Marsicano, G., & Busquets-García, A. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732708994.793550660
Yang, X. (2007) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1090653.544354
ТЕРАПЕВТИЧЕСКИЕ ЭФФЕКТЫ КАННАБИНОИДОВ ПРИ ПАТОЛОГИИ ЦЕНТРАЛЬНОЙ НЕРВНОЙ СИСТЕМЫ (ОБЗОР ЛИТЕРАТУРЫ)
Колесников, А. Н., Гридасова, Е. И., & Абрамова, Е. А. (2023) · Military and tactical medicine Emergency medicine · doi:10.55359/2782-3296.2023.90.22.013
Wójcik, A., Górny, A., Chwiejczak, J., Młynarska, J., Kościan, J., Szczerkowska, K., Seroka, A., Mitkowska, M., Rybicka, M., & Obrębski, M. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.71.49808
Campbell, M. G., Green, I., Pinto, S. R., & Uchida, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00131-5
Sparse innervation and local heterogeneity in the vibrissal corticostriatal projection
Amroune, K., Fontolan, L., Baude, A., Robbe, D., & Bureau, I. (2025) · eLife · doi:10.7554/elife.106621.3
Sparse innervation and local heterogeneity in the vibrissal corticostriatal projectionPreprint
Amroune, K., Fontolan, L., Baude, A., Robbe, D., & Bureau, I. (2025) · eLife · doi:10.7554/elife.106621.2
García-Mata, M., Laville, A., Tapia, D., Galarraga, E., & Bargas, J. (2025) · Neuroscience Letters · doi:10.1016/j.neulet.2025.138361
Marshall, J. J., Xu, J., Yeh, N.-H., Yun, S., Nomura, T., Armstrong, J. N., Parker, J. G., & Contractor, A. (2025) · eLife · doi:10.7554/elife.98122.2
Nanoscale synaptic remodeling at corticostriatal circuits predicts flexible action controlPreprint
Paget-Blanc, V., Zöldi, M., Cavaccini, A., Miczán, V., Dudok, B., Katona, I., & Tonini, R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.30.684628
Potential mechanisms of endocannabinoid release
Lupica, C. R. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00006-2
Cholinergic contributions to Parkinsonian symptoms and l-DOPA-induced dyskinesia
Tubert, C., Paz, R. M., Stahl, A. M., & Murer, M. G. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-21992-4.00008-7
Chan, V. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
Pontes, F. M. M., de Oliveira, N. K. S., Silva, A. C. D. J., de Souza, F. N., Ramos, J. S., Francisco, V. C. C., & Hage-Melim, L. I. D. S. (2026) · OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA · doi:10.55905/oelv24n1-082
Metadata
- Authors
- Kreitzer, A. C., & Malenka, R. C.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Malenka, Robert C.
- Venue
- Nature
- Published
- 2007-02
- Volume
- 445
- Issue
- 7128
- Pages
- 643-647
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003314029
- Cited by
- 735
- References
- 35
- Citations by year
- 2026: 12 · 2025: 21 · 2024: 21 · 2023: 17 · 2022: 17 · 2021: 34 · 2020: 28 · 2019: 41 · 2018: 41 · 2017: 45 · 2016: 37 · 2015: 34 · 2014: 37 · 2013: 31 · 2012: 47
- FWCI
- 44.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- striatum, indirect pathway, direct pathway, medium spiny neurons, dopamine D2 receptor, basal ganglia, motor impairment, synaptic plasticity, NMDA receptor currents, release probability, transgenic mouse model, therapeutic target, Huntington's disease, substantia nigra pars reticulata
- MeSH terms
- Animals, Benzamides, Carbamates, Disease Models, Animal, Dopamine, Mice, Transgenic, Morpholines, Naphthalenes, Neuronal Plasticity, Parkinson Disease, Piperidines, Psychomotor Performance, Pyrazoles, Reserpine, Synapses, Receptors, N-Methyl-D-Aspartate, Oxidopamine, Neostriatum, Receptors, Dopamine D2, Excitatory Postsynaptic Potentials, Long-Term Synaptic Depression, Receptor, Cannabinoid, CB1, Benzoxazines, Mice, Cannabinoid Receptor Modulators, Endocannabinoids, Dopamine D2 Receptor Antagonists, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review